Chemoinformaics analysis of 9-hydroxydecanoic-acid
Molecular Weight | 366.434 | nRot | 1 |
Heavy Atom Molecular Weight | 338.21 | nRig | 1 |
Exact Molecular Weight | 366.191 | nRing | 3 |
Solubility: LogS | -7.639 | nHRing | 3 |
Solubility: LogP | 12.683 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 19 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 56.3122 |
nHD | 2 | BPOL | 35.5778 |
QED | 0.108 |
Synth | 1.717 |
Natural Product Likeliness | 0.226 |
NR-PPAR-gamma | 0.159 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -5.369 |
MDCK | 0.00000269 |
BBB | 0.002 |
PPB | 1.00143 |
VDSS | 4.112 |
FU | 0.00656982 |
CYP1A2-inh | 0.029 |
CYP1A2-sub | 0.127 |
CYP2c19-inh | 0.098 |
CYP2c19-sub | 0.049 |
CYP2c9-inh | 0.015 |
CYP2c9-sub | 0.985 |
CYP2d6-inh | 0.035 |
CYP2d6-sub | 0.026 |
CYP3a4-inh | 0.129 |
CYP3a4-sub | 0.011 |
CL | 4.179 |
T12 | 0.016 |
hERG | 0.673 |
Ames | 0.006 |
ROA | 0.007 |
SkinSen | 0.977 |
Carcinogencity | 0.016 |
EI | 0.91 |
Respiratory | 0.538 |
NR-Aromatase | 0.052 |
Antiviral | Yes |
Prediction | 0.742863 |